Clinical ResearchSchistosomiasis Heart DiseaseSurvival in Schistosomiasis-Associated Pulmonary Arterial Hypertension
Schistosomiasis Heart Disease
Under an Elsevier user license
open archive
Key Words
schistosomiasis
pulmonary hypertension
survival
Abbreviations and Acronyms
IPAH
idiopathic pulmonary arterial hypertension
mPAP
mean pulmonary artery pressure
PAH
pulmonary arterial hypertension
PAOP
pulmonary artery occlusion pressure
PH
pulmonary hypertension
PVR
pulmonary vascular resistance
Sch-PAH
schistosomiasis-associated pulmonary arterial hypertension
6MWT
length in nonencouraged 6-min walk test
Cited by (0)
Drs. dos Santos Fernandes, Jardim, and Hovnanian has received lecture fees from Actelion and Pfizer. Drs. Hoette and Silvia Souza report that they have no relationships to disclose. Dr. Dias has received lecture fees from Actelion. Dr. Humbert is an investigator and a member of the scientific advisory board with Actelion, Bayer Schering, GlaxoSmithKline, Novartis, Pfizer, and United Therapeutics. Dr. Rogerio Souza has received consultancy and/or lecture fees from Actelion, Pfizer, and GlaxoSmithKline.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.